DNCA Finance’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.19M Hold
14,335
0.35% 49
2026
Q1
$7.05M Buy
14,335
+9,065
+172% +$4.92M 0.4% 43
2025
Q4
$3.05M Sell
5,270
-530
-9% -$300K 0.18% 64
2025
Q3
$2.81M Sell
5,800
-15,150
-72% -$7.05M 0.19% 63
2025
Q2
$8.49M Sell
20,950
-2,000
-9% -$836K 0.65% 42
2025
Q1
$11.4M Sell
22,950
-3,650
-14% -$1.98M 0.95% 29
2024
Q4
$13.8M Buy
26,600
+3,300
+14% +$1.81M 1.08% 29
2024
Q3
$14.4M Sell
23,300
-3,400
-13% -$2.01M 1.24% 25
2024
Q2
$14.8M Buy
+26,700
New +$15.3M 1.27% 20

Other funds holding TMO

DNCA Finance's TMO Position: Q2 2026 in Review

DNCA Finance held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 14,335 shares worth $7.19M. The position accounts for 0.35% of the portfolio, ranked #49.

DNCA Finance first reported a position in TMO in Q2 2024 and has held it in 9 quarters since. The position peaked at $14.8M in Q2 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • DNCA Finance held 14,335 shares of Thermo Fisher Scientific worth $7.19M as of Q2 2026.
  • DNCA Finance left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.35% of DNCA Finance's portfolio in Q2 2026, its #49 holding.
  • DNCA Finance first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 9 quarters since.
  • DNCA Finance's Thermo Fisher Scientific position peaked at $14.8M in Q2 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on DNCA Finance's 13F filing for Q2 2026, filed 13 Aug 2026.